Search Results for: U.S.

By Kuldip K. Ambastha Eastman Kodak Company (KODK) was prominent in the news again this week. During the week of July 27 – 31, 2020, Eastman Kodak Company stock did well because of the news that it received a $765 million American federal government loan, to help in making coronavirus-related drug ingredients. During this week, …

Continue reading “What Caught Our Attention in the Investment World? – Week of August 10 – 14, 2020”

By Kuldip K. Ambastha Biogen Inc. (BIIB) had a -7.5% return on Thursday, June 18, 2020. On this day, Biogen Inc. lost a legal dispute (over a patent) being heard by a U.S. district court. The patent dispute centered on a multiple sclerosis treatment drug called Tecfidera, which uses dimethyl fumarate as its main active …

Continue reading “What Caught Our Attention in the Investment World? – Week of June 15 – 19, 2020”

By Kuldip K. Ambastha The Dow Jones Industrial Average (DJIA) had a volatile ride this past week, due to several factors. Comments from Jerome Powell (the Chair of the U.S. Federal Reserve), GDP forecasting, unemployment rate (and jobless claims) data, and coronavirus pandemic data all played their own significant parts in the DJIA activity. The …

Continue reading “Dow Jones Index Volatility – Week of June 8 – 12, 2020”

By Kuldip K. Ambastha The American stock exchanges list a variety of companies from all over the world. Restrictions may be soon rolled out for Chinese (and other non-U.S.) companies listed on American stock exchanges, due to the Holding Foreign Companies Accountable (HFCA) Act already passed unanimously by the U.S. Senate on Wednesday, May 20, …

Continue reading “What Caught Our Attention in the Investment World? – Week of May 18 – 22, 2020”

By Kuldip K. Ambastha Jerome Powell, the Chair of the U.S. Federal Reserve, issued detailed comments this week. The American economy continues to be ravaged by the coronavirus pandemic. Additional fiscal support aid (e.g. another round of stimulus payments to Americans) will likely be needed for the American economy to recover. However, the Fed is …

Continue reading “Negative Interest Rates in the USA are Unlikely – Week of May 11 – 15, 2020”

By Kuldip K. Ambastha The Dow Jones had three down and two up days this week. The coronavirus pandemic has continued to wreak havoc all around the world, and the American capital markets were affected. During 1Q2020, the USA’s GDP (gross domestic product) annualized contraction rate was 4.8%. This figure was announced on Wednesday, April …

Continue reading “GDP Contraction, the Fed, and the Dow Jones – Week of April 27 – May 1, 2020”

By Kuldip K. Ambastha Per the table seen above, the Dow Jones Industrial Average (DJIA) took investors on a volatile ride this week. Down days were seen on Monday and Friday. Up days were seen on the Tuesday, Wednesday, and Thursday in between. This pattern in the DJIA was observed due to the federal government’s …

Continue reading “Government Stimulus and the Dow Jones – Week of March 23-27, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha Overstock.com, Inc. (OSTK) is an online retailer which offers a wide variety of products. Its stock fell by 17.4% on Tuesday, November 12, 2019 due to disappointing 3Q2019 results plus an investigation by the U.S. Securities and Exchange Commission (SEC). Specifically, a $0.89 loss per share was …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 11-15, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On October 28, 2019, New York-based Tiffany & Co.’s stock (TIF) jumped 31.6% for a record one-day gain. The stock surged due to the announcement of a potential $14.5 billion (USD) acquisition bid from LVMH Moët Hennessy (LVMH). LVMH is a Paris-based French company headed by the …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 28-November 1, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On October 22, 2019, Biogen Inc. (BIIB) delivered a 26.1% return for the day. This was the stock’s largest one-day percentage return in 23 years. Its Alzheimer’s drug (aducanumab) had previously been written off as a failure, but now will be getting a second chance at approval …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 21-25, 2019”